KDLY (Kindly MD Inc) Enterprise Value-to-Revenue Multiple

Public company logo of Kindly MD Inc (KDLY)

Kindly MD, Inc. (KDLY) is a micro-cap asset with limited transparency, where management is striving to prove its ability to grow the franchise. Cash flow stability depends on government funding and legal regulations; meanwhile, the team is successfully expanding its clinic network while controlling costs. The EV/Sales multiple reflects the business valuation dynamics, with the indicator currently standing at 5949.54.

Kindly MD, Inc. - KDLY Enterprise Value-to-Revenue Ratio (period 11/23/2025 - 11/20/2026)

Financial and market metric breakdowns for Kindly MD Corp (KDLY)

- share price and expert price forecast:
- money and cash flow information:
Fundamental company valuation:KDLY (kindlymd.com)
Finished products of Kindly MD Inc

The scaling of Kindly MD, Inc. (KDLY) within the inelastic demand niche for alternative therapy is clearly reflected in the enterprise value-to-revenue multiple. This ratio correlates the total enterprise value with annual turnover, excluding debt load, allowing investors to assess the market value of a single dollar of sales and determine the degree of the company's undervaluation given its significant pricing power.

Competitor analysis

Enterprise Value-to-Revenue Multiple hcahealthcare.com|THC: EV/Sales Multiple|FMS - Total Company Value-to-Revenue Ratio|Company Value to Revenue SOLV|Encompass (EHC) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Universal Health Services, Inc. (UHS)|DaVita Inc. - Company Value to Revenue Ratio|Enterprise Value-to-Revenue Ratio RadNet Corp RDNT|EV/Sales Multiple Option Care OPCH|Surgery Partners Inc - EV/Sales Multiple|PINC (Premier Corp) - Company Value to Revenue Ratio|nationalvision.com (EYE) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue Progyny|Company Value to Revenue ARDT|EV/Sales Multiple Select Medical Corporation|Company Value to Revenue ASTH (Astrana Health)|Company Value to Revenue Pediatrix MD|U.S. Physical Therapy - Company Value to Revenue|Business Value to Revenue PNTG|Organogenesis - EV/Sales Multiple|NUTX (Nutex Health) - Company Value to Revenue Ratio|AUNA (Auna) - Company Value to Revenue|Enterprise Value to Sales Volume SBC (SBC Medical Group Holdings)|Enterprise Value-to-Revenue Ratio Evolus, Inc.|Community Health Systems, Inc. (CYH) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Beauty Health (SKIN)|MediWound, Ltd. - Company Value to Revenue Ratio|EV/Sales Multiple BTMD (Biote)|Enterprise Value-to-Revenue Coefficient JYNT (The Joint Corp.)|DCGO - Enterprise Value-to-Revenue Ratio|PIII: Enterprise Value-to-Revenue Ratio|GANX: EV/Sales Multiple|Company Value to Revenue EUDA Health|BMGL (Basel Medical Group) - EV/Sales Multiple|CLGN - Enterprise Value-to-Sales Ratio|Enterprise Value-to-Revenue Ratio Cuprina Holdings (CUPR)|Total Company Value-to-Revenue Ratio Concord Medical Services|EV/Sales Multiple AMS (ashs.com)|MEDIROM Healthcare Group Inc. (MRM) - Enterprise Value-to-Revenue Multiple|ALBT: Company Value to Revenue|Business Value to Revenue DHAI (DIH Holding US Inc.)|XAGE (Carmell Therapeutics) - Company Value to Revenue|NIVF (NewGenIvf Group Limited) - Enterprise Value-to-Revenue Ratio|ATIP (ATI Physical Therapy Inc.) - EV/Sales Multiple|EV/Sales Multiple CareMax Inc.|Enterprise Value-to-Revenue Ratio ModivCare Corp (MODV)|Total Company Value-to-Revenue Ratio Novo Integrated Sciences|SunLink Health Systems, Inc. - Company Value to Revenue|imacholdings.comm (BACK) - Enterprise Value-to-Revenue Multiple